title: [The hepatotropic activity of runihol and ademethionine against experimental liver damage caused by first-line antituberculosis drugs].
abstract: Experiments on 62 male albino outbred rats investigated the impact of 14-day use of the oral hepatotropic agents ademethionine and runihol in different doses in liver damage caused by a antituberculosis combination (HRZ). HRZ-induced liver damage was shown to be accompanied by the development of cytolysis and cholestasis. The test drugs in the doses under study had a mixed effect, by reducing the magnitude of biochemical manifestations of these syndromes. Both drugs favored the recovery of the structure of the liver and the reduction of the extent of carbohydrate, protein, and fat dystrophies of the organ. As in previous investigations, ademethionine was found to have enhanced activity of alterative processes in the liver.
authors: D S
authors: DS
authors: Sukhanov
authors: T I
authors: TI
authors: Vinogradova
authors: N V
authors: NV
authors: Zabolotnykh
authors: M L
authors: ML
authors: Vitovskaia
authors: A L
authors: AL
authors: Kovalenko
mesh_terms: D000818:Animals; D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D002779:Cholestasis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051381:Rats; D012436:S-Adenosylmethionine / Q000008:administration & dosage* / Q000097:blood
chemical_list: D000995:Antitubercular Agents; D012436:S-Adenosylmethionine